Inventor · disambiguated record
Michael L. Curtin
Also filed as: CURTIN MICHAEL · CURTIN MICHAEL L
21 granted patents·23 pending applications·441 citations·filing 1994–2018
94Inventor score
Top patents by PatentIndex Score
44 records- 0197US6294573B1Reverse hydroxamate inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 2000·Granted Sep 25, 2001·131 cites·17 claims
- 0295US8637529B2Pyrazolo[3,4-d]pyrimidine compoundsWOLLER KEVIN R·Filed 2011·Granted Jan 28, 2014·112 cites·17 claims
- 0393US5486525APlatelet activating factor antagonists: imidazopyridine indolesABBOTT LAB·Filed 1994·Granted Jan 23, 1996·136 cites·10 claims
- 0490US8975398B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 10, 2015·13 cites·13 claims
- 0583US9187472B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 17, 2015·5 cites·1 claims
- 0682US7202363B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2004·Granted Apr 10, 2007·12 cites·9 claims
- 0776US9193723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 24, 2015·2 cites·18 claims
- 0876US8426408B2Pyrimidine inhibitors of kinasesCURTIN MICHAEL·Filed 2010·Granted Apr 23, 2013·7 cites·14 claims
- 0974US9296723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·1 cites·8 claims
- 1073US9302989B2NAMPT and rock inhibitorsCURTIN MICHAEL L·Filed 2011·Granted Apr 5, 2016·4 cites·20 claims
- 1170US7737160B2Thienopyridine and furopyridine kinase inhibitorsABBOTT LAB·Filed 2007·Granted Jun 15, 2010·2 cites·16 claims
- 1269US8273736B2Thienopyridine and furopyridine kinase inhibitorsBETSCHMANN PATRICK·Filed 2009·Granted Sep 25, 2012·1 cites·14 claims
- 1369US7560552B2Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jul 14, 2009·3 cites·2 claims
- 1469US2010076051A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2009·Application pending·0 cites
- 1568US8722890B2Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profileMICHAELIDES MICHAEL R·Filed 2012·Granted May 13, 2014·1 cites·7 claims
- 1664US5985911AC-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretionABBOTT LAB·Filed 1997·Granted Nov 16, 1999·10 cites·13 claims
- 1761US7129260B2Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2004·Granted Oct 31, 2006·1 cites·15 claims
- 1855US9758511B2NAMPT inhibitorsABBVIE INC·Filed 2016·Granted Sep 12, 2017·0 cites·7 claims
- 1955US8436179B2Kinase inhibitor with improved solubility profileMICHAELIDES MICHAEL R·Filed 2012·Granted May 7, 2013·0 cites·2 claims
- 2054US2018193315A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2018·Application pending·0 cites
- 2153US2018071262A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2017·Application pending·0 cites
- 2252US2016184281A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 2352US2017065575A1Nampt inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 2452US2017135994A9Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 2551US9334264B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted May 10, 2016·0 cites·11 claims
- 2651US2006287370A1Isoindolinone kinase inhibitorsCURTIN MICHAEL L·Filed 2006·Application pending·0 cites
- 2751US2006276490A1Thiopyrimidine and isothiazolopyrimidine Kinase InhibitorsMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 2847US2007135387A1Inhibitors of protein kinasesMICHAELIDES MICHAEL R·Filed 2006·Application pending·0 cites
- 2947US2015141398A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 3047US2016235716A1Spirocyclic hat inhibitors and methods for their useABBVIE INC·Filed 2015·Application pending·0 cites
- 3144US2005026944A1Thienopyridine and furopyridine kinase inhibitorsFiled 2004·Application pending·0 cites
- 3244US2016193209A1Nampt inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3343US9957274B2Indane inhibitors of EED and methods of their useABBVIE INC·Filed 2017·Granted May 1, 2018·0 cites·9 claims
- 3443US2003225273A1Thiopyrimidine and isothiazolopyrimidine kinase inhibitorsFiled 2003·Application pending·0 cites
- 3541US2005020619A1Thienopyridine kinase inhibitorsFiled 2003·Application pending·0 cites
- 3640US9796708B2Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitorsABBVIE INC·Filed 2014·Granted Oct 24, 2017·0 cites·11 claims
- 3739US2002007060A1Reverse hydroxamate inhibitors of matrix metalloproteinasesFiled 2001·Application pending·0 cites
- 3839US2002177594A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 3938US2002019527A1Substituted phenyl farnesyltransferase inhibitorsFiled 2001·Application pending·0 cites
- 4038US2017253562A1Nampt InhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 4135US2002103192A1Inhibitors of histone deacetylaseFiled 2001·Application pending·0 cites
- 4235US2016031813A1Nampt InhibitorsCURTIN MICHAEL L·Filed 2011·Application pending·0 cites
- 4333US2011275630A1Isoindolinone kinase inhibitorsABBOTT LAB·Filed 2010·Application pending·0 cites
- 4429US2012122924A1Nampt inhibitorsCURTIN MICHAEL L·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →